Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies. (Q53092961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Mohsin Y Lone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Anu Manhas

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Prakash C Jha

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

12 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biomolecular Structure and Dynamics

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

2951-2965

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

Genomic-scale prioritization of drug targets: the TDR Targets database

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Density-functional thermochemistry. III. The role of exact exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

International Tables for Crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

The first chemical synthesis of the core structure of the benzoylhydrazine-NAD adduct, a competitive inhibitor of the Mycobacterium tuberculosis enoyl reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Predicting natural product value, an exploration of anti-TB drug space.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Chemical synthesis, biological evaluation and structure–activity relationship analysis of azaisoindolinones, a novel class of direct enoyl-ACP reductase inhibitors as potential antimycobacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

An introduction to ROC analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Towards a new tuberculosis drug: pyridomycin - nature's isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Quantifying biogenic bias in screening libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Synthesis and antimycobacterial activity of 2,1'-dihydropyridomycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

ZINC--a free database of commercially available compounds for virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

A hierarchical approach to all-atom protein loop prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Comparison of simple potential functions for simulating liquid water

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Pharmacophore modeling in drug discovery and development: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Identification of compounds with potential antibacterial activity against Mycobacterium through structure-based drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

The challenge of new drug discovery for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

CoMFA based de novo design of pyrrolidine carboxamides as inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Density-functional exchange-energy approximation with correct asymptotic behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Lead- and drug-like compounds: the rule-of-five revolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Identification of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors: A combined in-silico and in-vitro analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Role of miR-1 and miR-133a in myocardial ischemic postconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Global tuberculosis drug development pipeline: the need and the reality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Mycolic acids: structures, biosynthesis, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Evaluation of electronic, lipophilic and membrane affinity effects on antiproliferative activity of 5-substituted-2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles against various human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Time-Dependent Diaryl Ether Inhibitors of InhA: Structure-Activity Relationship Studies of Enzyme Inhibition, Antibacterial Activity, and in vivo Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

A fast flexible docking method using an incremental construction algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Current progress in natural product-like libraries for discovery screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Reversible multiple time scale molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Molecular properties that influence the oral bioavailability of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Accurate spin-dependent electron liquid correlation energies for local spin density calculations: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Mechanism of thioamide drug action against tuberculosis and leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Antibacterial targets in fatty acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

The reductase steps of the type II fatty acid synthase as antimicrobial targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Inhibiting bacterial fatty acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

Molecular dynamics with coupling to an external bath

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2017.1372313

10.1080/07391102.2017.1372313

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28849732%20AND%20SRC:MED&resulttype=core&format=json